Skip to main content

Life sciences

We advise our Life Sciences clients on their most complex, transformative deals

We leverage our deep understanding of the sector to provide our Life Sciences clients with integrated advice, enabling them to navigate their most important and challenging legal needs.

Many of the lawyers in our team have life sciences backgrounds and have experience working in the industry.

We offer clients a genuine interest and deep understanding of the sector, combined with integrated and dedicated advice to achieve clients’ objectives in ways which are commercially viable and practically achievable.

Our clients include companies active in pharmaceuticals, biotechnology and medical devices, as well as other organizations such as healthcare providers, regulatory authorities and academic institutions.

We help our clients address a wide range of issues across the life sciences industry, including:

  • M&A
  • licenses and collaborations, joint ventures and other strategic alliances
  • antitrust, competition and trade
  • regulatory support
  • litigation and arbitration
  • intellectual property (IP)

We offer clients worldwide support from a broad and fully-integrated legal team, drawn from corporate, antitrust, IP, regulatory, litigation and product liability groups.

We also provide tax, employment and environmental support for clients.

Client successes

  • on its portfolio transformation, including the asset swap with GSK (oncology, OTC and vaccines assets) and the sale of its animal health business to Eli Lilly.
  • on the $5.2bn acquisition of Xiidra from Takeda/Shire.

  • on all business aspects of the carve-out of its worldwide consumer healthcare business.
  • on the €20bn asset swap (consumer health division swapped for animal health) with Sanofi.